esosinophilic esophagitis

Dupixent clears PhIII trial in new disease as blockbuster looks to expand past Regeneron-Sanofi split
Endpoints
Wed, 05/27/20 - 10:27 am
Dupixent
Sanofi
Regeneron
esosinophilic esophagitis
EoE
clinical trials